Related Experiment Video

Updated: Jul 17, 2026

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment
07:29

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment

Published on: April 22, 2019

Vaccine-based approaches to squamous cell carcinoma of the head and neck

X Zhang1, J A Moche, D Farber

  • 1Department of Otorhinolaryngology-Head and Neck Surgery, University of Maryland School of Medicine, Baltimore, MD 21201-1619, USA.

Oral Diseases
|January 24, 2007
PubMed

Insights

Vaccine strategies for head and neck squamous cell carcinoma show limited success. Future research must analyze past failures and successes to improve vaccine efficacy for better disease control and survival.

Area of Science:

  • Oncology
  • Immunology
  • Vaccinology

Background:

  • Advanced squamous cell carcinoma of the head and neck (HNSCC) presents a significant therapeutic challenge.
  • Current vaccine-based treatments for HNSCC have demonstrated very limited clinical success.

Purpose of the Study:

  • To review the efficacy and limitations of current protective and therapeutic vaccine strategies for HNSCC.
  • To identify key factors contributing to the limited success of vaccines in HNSCC treatment.
  • To propose future research directions for improving vaccine efficacy in HNSCC.

Main Methods:

  • Comprehensive literature review of vaccine strategies for HNSCC.
  • Analysis of successes and failures in preclinical and clinical studies.
  • Characterization of the utility and limitations of various vaccine approaches.

Main Results:

  • Vaccine approaches for HNSCC have historically shown minimal impact on disease control and patient survival.
  • Understanding the root causes of past successes and failures is crucial for advancing vaccine development.
  • Existing strategies face limitations in effectively preventing or treating HNSCC.

Conclusions:

  • Significant improvements in vaccine efficacy are needed for both disease control and survival in HNSCC.
  • Future research should focus on novel strategies informed by a thorough analysis of previous outcomes.
  • Defining new directions is essential for the successful development of HNSCC vaccines.

More Related Videos

Translationally-Relevant Tumor Resection Model for Murine Preclinical Models of Oral Squamous Cell Carcinoma07:59

Translationally-Relevant Tumor Resection Model for Murine Preclinical Models of Oral Squamous Cell Carcinoma

Published on: April 3, 2026

Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma06:11

Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma

Published on: April 20, 2018

Related Concept Videos

Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Skin Cancer01:30

Skin Cancer

Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Vaccinations01:51

Vaccinations

Overview